HOME >> MEDICINE >> NEWS
Anti-coagulation drugs found to have different effects in diabetics after heart attack

CHICAGO -- In a sub-analysis of data from an earlier trial comparing the ability of three agents used to restore blood flow to patients soon after heart attacks, researchers have found that drugs used to prevent blood coagulation appear to have different effects in heart patients with diabetes.

These findings, coupled with an assessment of ease of administration and cost compared to other drugs, leads researchers from Duke University Medical Center to recommend the drug enoxaparin, which is a low-molecular weight heparin, for acute heart attack patients with diabetes.

The Duke team reported the results of its analysis today (Nov. 20, 2002) at the 75th annual scientific session of the American Heart Association.

When heart attack patients are rushed to the emergency room, physicians immediately try to restore blood flow to the heart, usually by giving medications that dissolve clots in the coronary arteries. Since no one drug has been totally effective on its own in opening clogged arteries and keeping them open, researchers have tried different combinations of agents.

Thus was born the ASSENT-3 trial, the results of which were published in August 2001 in the journal Lancet. The trial enrolled 6,116 patients and documented the combined rates of death, recurrent heart attack or refractory chest pain. They then used this composite endpoint to measure the effectiveness of three different combinations of drugs.

All patients entered the hospital within six hours of a heart attack and were given varying doses of tenecteplase, a genetically altered version of the well-known clot-buster t-PA, which quickly dissolves the blood clot. Patients were then randomized to receive additional agents intended to keep the vessels clear: the blood-thinner enoxaparin; the blood-thinner unfractionated heparin plus abciximab (an agent that keeps platelets in the blood from clumping); or unfractionated heparin alone.

ASSENT-3 found that both th
'"/>

Contact: Richard Merritt
merri006@mc.duke.edu
919-684-4148
Duke University Medical Center
20-Nov-2002


Page: 1 2 3

Related medicine news :

1. UW research shows risk factors for relapse among health care professionals who abuse drugs
2. New studies show mixed results on epilepsy drugs and birth defects
3. Newly discovered pathway might help in design of cancer drugs
4. Study examines consequences of Thailands war on drugs
5. Computational tool predicts how drugs work in cells, advancing efforts to design better medicines
6. Three anti-platelet drugs used in combination are safe
7. HIV patients may be at risk of heart problems when taking protease inhibitor drugs
8. Clot-busting drugs may help detect potentially deadly leg clots
9. Herb used to treat diabetes works like modern-day prescription drugs, study suggests
10. Penn study shows how next-generation diabetic drugs could work more selectively
11. Study shows drugs such as Vioxx and Celebrex were widely over-used long before recent problems

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/4/2019)... CARDIFF BY THE SEA, Calif. (PRWEB) , ... ... ... Prickly Pear fruit, trademarked as Tex-OE, Opuntia Mesocarp Extract®, provides protection from disruptions ... amazing extract, effective at countering the menace of Jet Lag, is available in ...
(Date:12/4/2019)... ... December 04, 2019 , ... Healthcare Real Estate Insights™ ... national awards dedicated to recognizing excellence in the areas of healthcare real estate ... nine different categories during the GlobeSt Healthcare Conference today in Scottsdale, Ariz. , ...
(Date:12/4/2019)... (PRWEB) , ... December 04, 2019 , ... UNC Health ... easily find their way around the campuses of UNC Medical Center in Chapel Hill ... two hospitals, parking garages, clinics and more. , The free interactive app, developed by ...
(Date:12/2/2019)... YORK (PRWEB) , ... December 02, 2019 , ... More ... year at midnight on December 31. While many people spend their tax-free funds throughout ... ball drops on New Year’s Eve. In an effort to help account holders use ...
(Date:12/2/2019)... ... December 02, 2019 , ... Interim HealthCare Inc. , a ... the 2019 Workforce: Optimas Awards . Selected for its multi-pronged approach to building ... help combat the nation’s caregiver shortage. By 2025, the U.S. will need to hire ...
Breaking Medicine News(10 mins):
(Date:12/4/2019)... FOREST, Calif. (PRWEB) , ... December 04, 2019 ... ... technology company providing healthcare professionals with minimally invasive technologies to treat chronic pain ... procedures performed with the Tenex Health TX® technology. , Dr. Bernard ...
(Date:12/4/2019)... (PRWEB) , ... December 04, 2019 , ... ... physicians to better manage their COPD patient’s symptoms, joined forces nearly a year ... patients immediate access to in-person care at times when the attention is most ...
(Date:12/2/2019)... , ... December 02, 2019 , ... ... of A Mission for Michael, an intensive mental health facility, announced it has ... oversee client relations, business development and national advocacy efforts. , "We are proud ...
Breaking Medicine Technology:
Cached News: